Compound 1966
Identifiers
- Canonical SMILES:
CCCC(=O)N1CCC(CC1)C(=O)N(C)Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1
- IUPAC name:
1-butanoyl-N-[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl]-N-methylpiperidine-4-carboxamide
- InChi:
InChI=1S/C31H29Cl2F3N4O4/c1-3-4-27(41)40-9-7-17(8-10-40)30(44)39(2)16-18-11-20(32)13-23(28(18)42)26-14-21(24(15-37)29(43)38-26)22-12-19(31(34,35)36)5-6-25(22)33/h5-6,11-14,17,42H,3-4,7-10,16H2,1-2H3,(H,38,43)
- InChiKey:
WGLORHLIIYUIIF-UHFFFAOYSA-N
External links
![]() 16747688 |
![]() CHEMBL272921 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Survivin dimer | 7.22 | cancer | Stabilization |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 648.15 g/mol | |||
HBA | 8 | |||
HBD | 2 | |||
HBA + HBD | 10 | |||
AlogP | 4.45 | |||
TPSA | 110.94 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1016/j.bmcl.2007.03.042 | 25b | BIRC5 O15392 |
|
Biochemical assay | Fluorescence Polarization | pKd (dissociation constant, -log10) | 7.22 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5729 | 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | DB08705 | |
0.4576 | Losmapimod | DB12270 | |
0.4559 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE | DB07025 | |
0.4372 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE | DB07075 | |
0.4360 | Talnetant | DB06429 | |
0.4353 | CPI-1205 | DB14581 | |
0.4340 | JPC-3210 | DB15609 | |
0.4208 | Garenoxacin | DB06160 | |
0.4191 | Tazemetostat | DB12887 | |
0.4141 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | DB07006 | |
0.4118 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid | DB07189 | |
0.4091 | 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID | DB07265 | |
0.4091 | N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE | DB08031 | |
0.4068 | (5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL | DB07213 | |
0.4061 | Topotecan | DB01030 |